BRAIN SARCOMA

BRAIN SARCOMA was reported 30 times

BRAIN SARCOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 17 0.0002
1 Nucleoside Metabolic Inhibitor [EPC] 18 0.0001
2 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
3 Folate Analog Metabolic Inhibitor [EPC] 17 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 3 0.0000
5 Corticosteroid [EPC] 13 0.0000
6 Acetylcholine Release Inhibitor [EPC] 1 0.0000
7 Alkylating Drug [EPC] 1 0.0000
8 Platinum-based Drug [EPC] 1 0.0000
9 Kinase Inhibitor [EPC] 2 0.0000
10 Vitamin D [EPC] 1 0.0000
11 Vitamin B12 [EPC] 1 0.0000
12 Vitamin C [EPC] 1 0.0000
13 Proton Pump Inhibitor [EPC] 1 0.0000
14 Tumor Necrosis Factor Blocker [EPC] 1 0.0000